Detailed financial statements for Marsh & McLennan Companies, Inc. (MRSH): income statement, balance sheet and cash-flow summary. Track margins, debt, liquidity and profitability trends year over year: ten fiscal years free and up to 20 with Premium.
Marsh & McLennan Companies, Inc. (MRSH) functions as a leading professional services organization, delivering expert guidance and innovative solutions to clients across the vital domains of risk management, strategic planning, and human capital. Based in New York City, the firm maintains a substantial global workforce, employing approximately 65,000 full-time professionals. This entity serves as the parent company for several prominent advisory and consulting brands.
Analysis Summary
Marsh & McLennan Companies, Inc. reported revenue of $26.98B in the most recent fiscal year, growing at a 5-year CAGR of 9.4%. Net income reached $4.16B, with a 15.6% 5-year CAGR.
Trailing-twelve-month margins: gross margin 42.4%, operating margin 21.6%, net margin 14.2%. Free cash flow grew at 10.5% CAGR over 5 years.
At the current price of $170.55, MRSH trades at a P/E of 20.79 and an ROE of 26.53%. Market capitalisation stands at $81.4B, placing it among large-cap names.
Balance sheet quality for MRSH: current ratio of 1.1, net debt of $18.76B. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Cash flow quality is strong: free cash flow of $5.00B represents 120% conversion of reported net income. High conversion (above 90%) suggests earnings translate cleanly into cash; lower conversion may indicate working capital tightness or accounting timing differences.
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.21B | $14.02B | $14.95B | $16.65B | $17.22B | $19.82B | $20.72B | $22.74B | $24.46B | $26.98B |
| Cost of Revenue | $7.69B | $8.09B | $8.61B | $9.73B | $10.13B | $11.43B | $12.07B | $13.10B | $14.00B | $15.58B |
| Gross Profit | $5.52B | $5.94B | $6.34B | $6.92B | $7.09B | $8.39B | $8.65B | $9.64B | $10.46B | $11.40B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $7.69B | $8.09B | $8.61B | $9.73B | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | $3.09B | $3.28B | $3.58B | $4.24B | $4.03B | $4.08B | $4.37B | $4.36B | $4.64B | $5.18B |
| Operating Income | $2.43B | $2.65B | $2.76B | $2.68B | $3.07B | $4.31B | $4.28B | $5.28B | $5.82B | $6.22B |
| EBITDA | $3.11B | $3.36B | $3.03B | $3.61B | $4.05B | $5.40B | $5.27B | $6.32B | $6.93B | $7.39B |
| Interest Expense | $189.0M | $237.0M | $290.0M | $524.0M | $515.0M | $444.0M | $469.0M | $578.0M | $700.0M | $960.0M |
| Pre-tax Income | $2.48B | $2.64B | $2.24B | $2.44B | $2.79B | $4.21B | $4.08B | $5.03B | $5.48B | $5.54B |
| Income Tax | $685.0M | $1.13B | $574.0M | $666.0M | $747.0M | $1.03B | $995.0M | $1.22B | $1.36B | $1.30B |
| Net Income | $1.77B | $1.49B | $1.65B | $1.74B | $2.02B | $3.14B | $3.05B | $3.76B | $4.06B | $4.16B |
| EPS | $3.41 | $2.91 | $3.26 | $3.44 | $3.98 | $6.20 | $6.11 | $7.60 | $8.25 | $8.48 |
| EPS (Diluted) | $3.37 | $2.87 | $3.23 | $3.41 | $3.94 | $6.13 | $6.04 | $7.53 | $8.18 | $8.43 |
| Shares Outstanding (Diluted) | $524.0M | $519.0M | $511.0M | $511.0M | $512.0M | $513.0M | $505.0M | $499.0M | $496.0M | $490.0M |
Income Statement (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|---|---|---|---|
| Revenue | $6.35B | $6.59B | $7.60B | $7.40B |
| Gross Profit | $2.46B | $2.66B | $3.47B | $3.26B |
| Operating Income | $1.17B | $1.22B | $1.75B | $1.90B |
| EBITDA | $1.47B | $1.50B | $1.58B | $1.20B |
| Net Income | $747.0M | $821.0M | $1.15B | $1.27B |
| EPS | $1.52 | $1.69 | $2.37 | $2.63 |
| EPS (Diluted) | $1.51 | $1.68 | $2.36 | $2.63 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.03B | $1.21B | $1.07B | $1.16B | $2.09B | $1.75B | $1.44B | $3.36B | $2.40B | $2.69B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $3.64B | $4.13B | $4.32B | $5.24B | $5.33B | $5.59B | $5.85B | $6.42B | $7.16B | $7.67B |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $4.88B | $5.56B | $5.93B | $7.07B | $8.12B | $8.26B | $18.96B | $21.75B | $22.12B | $23.20B |
| Property, Plant & Equipment | $725.0M | $712.0M | $701.0M | $2.78B | $2.75B | $2.71B | $2.43B | $2.42B | $2.36B | $2.29B |
| Goodwill | $8.37B | $9.09B | $9.60B | $14.67B | $15.52B | $16.32B | $16.25B | $17.23B | $23.31B | $24.34B |
| Intangible Assets | $1.13B | $1.27B | $1.44B | $2.77B | $2.70B | $2.81B | $3.03B | $2.63B | $4.82B | $5.21B |
| Total Assets | $18.19B | $20.43B | $21.58B | $31.32B | $33.03B | $34.39B | $44.11B | $48.03B | $56.48B | $58.71B |
| Accounts Payable | $1.97B | $2.08B | $2.23B | $2.75B | $3.05B | $3.17B | $3.28B | $3.40B | $3.40B | $3.65B |
| Short-term Debt | $312.0M | $262.0M | $314.0M | $1.22B | $517.0M | $17.0M | $268.0M | $1.62B | $519.0M | $1.27B |
| Total Current Liabilities | $4.08B | $4.26B | $4.92B | $6.68B | $6.56B | $6.65B | $17.83B | $19.80B | $19.52B | $21.06B |
| Long-term Debt | $4.50B | $5.22B | $5.51B | $10.74B | $10.80B | $10.93B | $11.23B | $11.84B | $19.43B | $18.32B |
| Total Liabilities | $11.92B | $12.99B | $13.99B | $23.41B | $23.79B | $23.17B | $33.37B | $35.66B | $42.95B | $43.40B |
| Retained Earnings | $12.39B | $13.14B | $14.35B | $15.20B | $16.27B | $18.39B | $20.30B | $22.76B | $25.31B | $27.77B |
| Total Equity | $6.19B | $7.36B | $7.51B | $7.79B | $9.10B | $11.01B | $10.52B | $12.19B | $13.34B | $15.10B |
| Total Debt | $4.81B | $5.49B | $5.82B | $14.22B | $13.58B | $13.16B | $13.47B | $15.44B | $21.86B | $21.45B |
| Net Debt | $3.78B | $4.28B | $4.76B | $13.07B | $11.49B | $11.41B | $12.03B | $12.08B | $19.46B | $18.76B |
| Working Capital | $802.0M | $1.30B | $1.01B | $389.0M | $1.56B | $1.61B | $1.13B | $1.95B | $2.60B | $2.14B |
Balance Sheet (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|---|---|---|---|
| Cash & Equivalents | $2.51B | $2.69B | $1.61B | $1.70B |
| Total Assets | $58.78B | $58.71B | $58.55B | $59.68B |
| Total Liabilities | $43.42B | $43.40B | $43.75B | $44.25B |
| Total Equity | $15.15B | $15.10B | $14.57B | $15.18B |
| Total Debt | $21.43B | $21.45B | $22.45B | $22.38B |
Cash Flow (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $1.79B | $1.51B | $1.67B | $1.77B | $2.05B | $3.17B | $3.09B | $3.80B | $4.06B | $4.23B |
| Depreciation & Amortization | $438.0M | $481.0M | $494.0M | $647.0M | $741.0M | $747.0M | $719.0M | $713.0M | $746.0M | $910.0M |
| Stock-based Compensation | $109.0M | $149.0M | $193.0M | $252.0M | $290.0M | $348.0M | $367.0M | $363.0M | $368.0M | $394.0M |
| Change in Working Capital | -$365.0M | -$616.0M | -$302.0M | -$696.0M | -$137.0M | -$645.0M | -$1.01B | -$908.0M | -$1.07B | -$518.0M |
| Operating Cash Flow | $2.01B | $1.89B | $2.43B | $2.36B | $3.38B | $3.52B | $3.46B | $4.26B | $4.30B | $5.29B |
| Capital Expenditure | -$253.0M | -$302.0M | -$314.0M | -$421.0M | -$348.0M | -$406.0M | -$470.0M | -$416.0M | -$316.0M | -$291.0M |
| Acquisitions | -$813.0M | -$655.0M | -$774.0M | -$4.23B | -$570.0M | -$775.0M | -$453.0M | -$993.0M | -$8.45B | -$652.0M |
| Stock Repurchased | -$839.0M | -$949.0M | -$742.0M | -$574.0M | 0 | -$1.16B | -$1.95B | -$1.15B | -$900.0M | -$2.01B |
| Dividends Paid | -$682.0M | -$740.0M | -$807.0M | -$880.0M | -$943.0M | -$1.03B | -$1.14B | -$1.30B | -$1.51B | -$1.70B |
| Free Cash Flow | $1.75B | $1.59B | $2.11B | $1.94B | $3.03B | $3.11B | $3.00B | $3.84B | $3.99B | $5.00B |
Cash Flow (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|---|---|---|---|
| Operating Cash Flow | $2.08B | $2.16B | -$688.0M | $1.52B |
| Capital Expenditure | -$72.0M | -$105.0M | -$62.0M | -$72.0M |
| Free Cash Flow | $2.01B | $2.06B | -$750.0M | $1.45B |
| Dividends Paid | -$445.0M | -$444.0M | -$440.0M | -$438.0M |
| Stock-based Compensation | $95.0M | $67.0M | $139.0M | $96.0M |
Growth & Margins (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue Growth (YoY) | +6.2% | +6.6% | +11.4% | +3.4% | +15.1% | +4.5% | +9.7% | +7.6% | +10.3% | |
| Net Income Growth (YoY) | -15.6% | +10.6% | +5.6% | +15.7% | +55.9% | -3.0% | +23.1% | +8.1% | +2.5% | |
| EPS Growth (YoY) | -14.7% | +12.0% | +5.5% | +15.7% | +55.8% | -1.5% | +24.4% | +8.6% | +2.8% | |
| Shares Change (YoY) | -1.0% | -1.5% | +0.0% | +0.2% | +0.2% | -1.6% | -1.2% | -0.6% | -1.2% | |
| FCF Growth (YoY) | -9.3% | +32.9% | -8.2% | +56.4% | +2.5% | -3.7% | +28.3% | +3.7% | +25.5% | |
| Gross Margin | 41.8% | 42.3% | 42.4% | 41.5% | 41.2% | 42.4% | 41.7% | 42.4% | 42.8% | 42.3% |
| Operating Margin | 18.4% | 18.9% | 18.5% | 16.1% | 17.8% | 21.8% | 20.7% | 23.2% | 23.8% | 23.1% |
| EBITDA Margin | 23.5% | 24.0% | 20.3% | 21.7% | 23.5% | 27.2% | 25.4% | 27.8% | 28.3% | 27.4% |
| Net Margin | 13.4% | 10.6% | 11.0% | 10.5% | 11.7% | 15.9% | 14.7% | 16.5% | 16.6% | 15.4% |
| FCF Margin | 13.3% | 11.3% | 14.1% | 11.7% | 17.6% | 15.7% | 14.5% | 16.9% | 16.3% | 18.5% |
| Effective Tax Rate | 27.6% | 42.9% | 25.6% | 27.3% | 26.7% | 24.6% | 24.4% | 24.4% | 24.9% | 23.6% |
Per-Share Data (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF Per Share | $3.35 | $3.07 | $4.14 | $3.80 | $5.93 | $6.06 | $5.93 | $7.70 | $8.04 | $10.21 |
| Dividends Per Share | $1.30 | $1.43 | $1.58 | $1.72 | $1.84 | $2.00 | $2.25 | $2.60 | $3.05 | $3.47 |
| Shares Outstanding (Basic) | $519.0M | $513.0M | $506.0M | $506.0M | $506.0M | $507.0M | $499.0M | $494.0M | $492.0M | $487.0M |
What to look at in Insurance
Insurers earn in 2 ways: underwriting well (combined ratio) and investing the float. Buffett built Berkshire that way.
- Op Margin 5y (Combined Ratio proxy) — Combined ratio proxy when our data does not include it. ≥10% 5y average = underwriting discipline (CR <100%)
- Book Value / Share growth — How Buffett measures Berkshire. The real value shareholders accumulate
- Debt / Equity — Leveraged insurers fail fast under catastrophes
- P/B (Price / Book) — Insurers are valued by book multiple. Here it is crossed with ROE (quality × valuation)
- Dividend growth streak — Consecutive years raising dividend per share — solid insurers stack decades
Profitability
| Return on Equity | 26.53% |
| Return on Invested Capital | 11.40% |
| Return on Assets | 6.67% |
| Gross Margin | 42.38% |
| Operating Margin | 21.62% |
| Net Margin | 14.24% |
Financial Health
| Debt / Equity | 1.47 |
| Current Ratio | 1.14 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 2.76 |
Key Ratios (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | 19.82 | 27.97 | 24.46 | 32.39 | 29.40 | 28.04 | 27.08 | 24.93 | 25.75 | 21.88 |
| P/B | 5.67 | 5.67 | 5.37 | 7.23 | 6.50 | 8.00 | 7.85 | 7.68 | 7.83 | 5.98 |
| P/S | 2.66 | 2.98 | 2.70 | 3.39 | 3.44 | 4.45 | 3.99 | 4.12 | 4.27 | 3.35 |
| Gross Margin | 41.8% | 42.3% | 42.4% | 41.5% | 41.2% | 42.4% | 41.7% | 42.4% | 42.8% | 42.3% |
| Operating Margin | 18.4% | 18.9% | 18.5% | 16.1% | 17.8% | 21.8% | 20.7% | 23.2% | 23.8% | 23.1% |
| Net Margin | 13.4% | 10.6% | 11.0% | 10.5% | 11.7% | 15.9% | 14.7% | 16.5% | 16.6% | 15.4% |
Related companies: AJG · AON · BRO · CB · ERIE · NTRS · PGR
Explore sector: Financial Services · Insurance - Brokers
More sections of MRSH: Overview · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks